North America Immunoassay Reagents and Devices Market - Size, Share, Demand, Industry Trends and Opportunities
North America Immunoassay Reagents and Devices Market, By Product (Reagents & kits, Analyzers), Platform (Chemiluminescence Immunoassays, Fluorescence Immunoassays, Enzyme Immunoassay, Radioimmunoassays and Others), Technique (Enzyme-Linked Immunosorbent Assays, Rapid Tests, Enzyme-Linked Immunospot, Western Blotting, Immuno-PCR and Other Techniques), Specimen Type (Blood, Urine, Saliva and Others), Application (Infectious Diseases, Oncology And Endocrinology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening and Other Applications), End User (Hospitals, Clinical Laboratories, Pharmaceutical And Biotechnology Companies, Blood Banks, Research & Academic Laboratories and Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028.
The immunoassay reagents and devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.7% in the forecast period of 2021 to 2028 and is expected to reach USD 10,178.81 million by 2028. Rising prevalence of diseases, which need technologically advanced products for diagnosis to avoid misinterpretation, is expected to fuel the growth of the immunoassay reagents and devices market in the forecast period.
Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report @
**Segments**
The North America immunoassay reagents and devices market is segmented by product type, technology, application, and end user. By product type, the market is divided into reagents & kits, analyzers, and software & services. Reagents & kits segment dominated the market due to the increasing usage of immunoassay kits in various diagnostic applications. The technology segment includes enzyme-linked immunosorbent assay (ELISA), radioimmunoassay (RIA), chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA), and others. ELISA holds the largest market share owing to its wide application in the diagnosis of infectious diseases and chronic conditions. Based on application, the market is categorized into infectious diseases, endocrinology, oncology, cardiology, autoimmune diseases, and others. The infectious diseases segment is expected to witness significant growth due to the rising prevalence of infectious diseases in the region. Lastly, by end user, the market is segmented into hospitals, clinical laboratories, pharmaceutical & biotechnology companies, and others.
**Market Players**
- Siemens Healthineers
- F. Hoffmann-La Roche Ltd
- Abbott
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Danaher
- Sysmex Corporation
- Ortho Clinical Diagnostics
- bioMérieux SA
- DiaSorin S.p.A.
The North America immunoassay reagents and devices market is witnessing substantial growth due to several factors. The increasing prevalence of chronic and infectious diseases, coupled with the rising demand for early and accurate diagnosis, is driving market growth. Technological advancements in immunoassay techniques, such as automation and miniaturization, are further boosting market expansion. Moreover, the growing adoption of immunoassay tests in drug development and monitoring is contributing to market growth. The COVID-19 pandemic has also propelled the demand for immunoassay reagents and devices for diagnostic purposes, thereby positively impacting the market.
Despite the growth prospects, the market faces certain challenges. The high cost associated with immunoassay tests and devices may hinder market growth, especially in developing economies. Additionally, the lack of skilled professionals to perform immunoassay tests accurately poses a challenge to market growth. Furthermore, stringent regulatory requirements for product approval and the presence of alternative diagnostic technologies may limit market expansion to some extent. However, collaborations and partnerships among key market players for product development and commercialization are expected to create lucrative opportunities in the North America immunoassay reagents and devices market.
In conclusion, the North America immunoassay reagents and devices market is poised for significant growth driven by the increasing burden of diseases, technological advancements, and the impact of the COVID-19 pandemic. Key players in the market are focusing on innovation and strategic collaborations to maintain their competitive edge. The market is likely to witness continued expansion as the demand for accurate and rapid diagnostic solutions persists in the healthcare industry.
Access Full 350 Pages PDF Report @
Table of Content:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: North America Immunoassay Reagents and Devices Market Landscape
Part 04: North America Immunoassay Reagents and Devices Market Sizing
Part 05: North America Immunoassay Reagents and Devices Market by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Browse Trending Reports:
North America Cancer Supportive Care Products Market
Middle East And Africa Cancer Supportive Care Products Market
Europe Cancer Supportive Care Products Market
Middle East And Africa Transfection Market
North America Transfection Market
Asia Pacific Transfection Market
Europe Transfection Market
Us Telestroke Market
Asia Pacific Surface Disinfectant Market
Asia Pacific Plastic Surgery Devices Market
Europe Plastic Surgery Devices Market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Email: corporatesales@databridgemarketresearch.com
"
